Pharmacokinetics of Multiple-Dose Levofloxacin in Hemodialysis Patients  Shuichi Tsuruoka, MD, PhD, Noritsugu Yokota, MD, PhD, Tokie Hayasaka, RN, Tetsuo.

Slides:



Advertisements
Similar presentations
The Rise of Renal Pathology in Nephrology: Structure Illuminates Function Vivette D. D'Agati, MD, Michael Mengel, MD American Journal of Kidney Diseases.
Advertisements

Fredrik Karlsson, MD, Angelo Modica, MD, Thomas Mooe, MD, PhD 
The Pharmacokinetics of Intradialytic Administration of Eculizumab in an Infant  Ji Lee, PharmD, Peace Imani, MD, Jessica Geer, C-PNP, Michael Braun, MD,
Renal Function Testing
Peritoneal dialysis American Journal of Kidney Diseases
Gregory L. Hundemer, MD, MPH, Andrew Z. Fenves, MD, Kristy M
Phosphate Kinetic Models in Hemodialysis: A Systematic Review
Hypertension in the hemodialysis patient and the “lag phenomenon”: insights into pathophysiology and clinical management  Uday M Khosla, MD, Richard J.
Metabolic and Hemodynamic Advantages of an Acetate-Free Citrate Dialysate in a Uremic Case of Congenital Methylmalonic Acidemia  Takako Saito, MD, Osamu.
Quiz Page March 2008 American Journal of Kidney Diseases
Dorian Schatell, MS, Meg Wise, PhD, Kristi Klicko, CHES, Bryan N
Surviving the First Year of Peritoneal Dialysis: Enduring Hard Times
Association of Physical Activity and Renal Function in Subjects With and Without Metabolic Syndrome: A Review of the Third National Health and Nutrition.
Amir Said Alizadeh Naderi, MD, Biff F. Palmer, MD 
Dialysis Facility Ownership and Epoetin Dosing in Hemodialysis Patients: A Dialysis Provider’s Perspective  J. Michael Lazarus, MD, Raymond M. Hakim,
Solute-Solver: A Web-Based Tool for Modeling Urea Kinetics for a Broad Range of Hemodialysis Schedules in Multiple Patients  John T. Daugirdas, MD, Thomas.
Urine Acidification After Ammonium Chloride
Quiz Page July 2009 American Journal of Kidney Diseases
Evaluation of the Potential Living Kidney Donor
Spurious Hyperphosphatemia in Patients on Hemodialysis With Catheters
Hai-yan Wang, MD, American Journal of Kidney Diseases
Focusing on Health Literacy Might Help Us Cross the Quality Chasm
Salt and Hypertension American Journal of Kidney Diseases
Karl D. Nolph, MD, American Journal of Kidney Diseases
Felicity C. Smith, BMedSci (Hons), Shaun S. Kumar, PhD, Timothy J
Dorothea Nitsch, MD, MSc  American Journal of Kidney Diseases 
Iva Gunnarsson, MD, PhD  American Journal of Kidney Diseases 
Hemoglobin Level and Transfusions in Patients on Maintenance Dialysis: Where the Rubber Meets the Road  Eduardo Lacson, MD, MPH, Franklin Maddux, MD 
Nosratola D. Vaziri, MD  American Journal of Kidney Diseases 
This Month in AJKD American Journal of Kidney Diseases
Usability Testing and Acceptance of an Electronic Medication Inquiry System for CKD Patients  Clarissa J. Diamantidis, MD, MHS, Marni Zuckerman, MA, Wanda.
Julie A. Wright Nunes, MD, MPH, Kerri L
Quiz Page July 2012 American Journal of Kidney Diseases
Hypertension in the hemodialysis patient and the “lag phenomenon”: insights into pathophysiology and clinical management  Uday M Khosla, MD, Richard J.
Use of Diuretics in Heart Failure: A Precarious Balance
Elevated Fibroblast Growth Factor 23 in a Patient With Metastatic Prostate Cancer and Hypophosphatemia  Casey L. Cotant, MD, Panduranga S. Rao, MD, DNB,
A Decade After the KDOQI CKD Guidelines: A Perspective From Mexico
A Role for Bromine Deficiency in Sleep Disturbances of Long-Term Dialysis Patients  Caterina Canavese, MD, Ester De Costanzi, MD, Piero Stratta, MD, Enrico.
Salicylate Intoxication as a Cause of Pseudohyperchloremia
Quiz Page April 2008 American Journal of Kidney Diseases
Study Designs in Patient-Oriented Research
Drug Dose Adjustments in Patients With Renal Impairment
Pharmacokinetics and Pharmacodynamics of Imipenem and Meropenem in Critically Ill Patients Treated With Continuous Venovenous Hemodialysis  David Afshartous,
Dmytro Khadzhynov, MD, Christian Joukhadar, MD, Harm Peters, MD 
Erratum American Journal of Kidney Diseases
Sulfamethoxazole Crystalluria
Long-term Outcomes of Acute Kidney Injury: The Power and Pitfalls of Observational/Population-Based Studies  Charuhas V. Thakar, MD  American Journal.
Arnold S. Relman, MD, American Journal of Kidney Diseases
Trial Quality in Nephrology: How Are We Measuring Up?
Kim Dao, MD, Haithem Chtioui, MD, Yimin Lu, MD, Cody J
Removal of Dabigatran by Hemodialysis
Making Music American Journal of Kidney Diseases
Differences in Blood Transfusion Trends Between US and UK Centers
Erratum American Journal of Kidney Diseases
In the Literature: Cognitive Impairment in Hemodialysis Patients
Achieving Fairness in Access to Kidney Transplant: A Work in Progress
Anil K. Saxena, MD, B.R. Panhotra, MD, PhD, MNAMS 
Quiz Page June 2009 American Journal of Kidney Diseases
Quiz Page June 2011 American Journal of Kidney Diseases
Jordi Goldstein-Fuchs, DSc, RD, RN, Denis Fouque, MD, PhD 
This Month in AJKD American Journal of Kidney Diseases
How to Manage Functional Vitamin K Deficiency in CKD
Dialysis Research and N-of-1 Trials: Made for Each Other?
Quiz Page January 2010 American Journal of Kidney Diseases
Clinical Practice Recommendations For Peritoneal Dialysis Adequacy
In Reply to ‘Plasma Clearance of Iohexol in Hemodialysis Patients Requires Prolonged Blood Sampling’  Tariq Shafi, MBBS, MHS, Andrew S. Levey, MD, Josef.
Maristela Böhlke, PhD  American Journal of Kidney Diseases 
Clinical Practice Guidelines for Peritoneal Dialysis Adequacy
Quiz page December 2003 American Journal of Kidney Diseases
This Month in AJKD American Journal of Kidney Diseases
Presentation transcript:

Pharmacokinetics of Multiple-Dose Levofloxacin in Hemodialysis Patients  Shuichi Tsuruoka, MD, PhD, Noritsugu Yokota, MD, PhD, Tokie Hayasaka, RN, Tetsuo Saito, MD, PhD, Kunihiro Yamagata, MD, PhD  American Journal of Kidney Diseases  Volume 58, Issue 3, Pages 498-499 (September 2011) DOI: 10.1053/j.ajkd.2011.05.014 Copyright © 2011 National Kidney Foundation, Inc. Terms and Conditions

Figure 1 Profile of plasma levofloxacin concentration during and after a hemodialysis (HD) session. Patients used 500 mg of the drug after HD on the first day and 250 mg 4 hours before HD on the third day. Blood sampling was performed just before and 2 and 4 hours after HD. Another sampling was performed just before the next HD session (44 hours after the end of the previous session). American Journal of Kidney Diseases 2011 58, 498-499DOI: (10.1053/j.ajkd.2011.05.014) Copyright © 2011 National Kidney Foundation, Inc. Terms and Conditions